暴露和反应预防与利斯佩里用于治疗动障碍:一项随机对照试验
Jolande M T M van de Griendt1,2, Danielle C Cath3,4, Agnes A A C M Wertenbroek5
1Behavioural Science Institute, Radboud University Nijmegen, Nijmegen, Netherlands.
Frontiers in psychiatry
|March 18, 2025
概括
行为疗法 (ERP) 和瑞斯佩里是治疗滴答障碍的有效方法. 随着时间的推移,ERP在改善生活质量和减少副作用方面显示出轻微的优势.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 图雷特乱和其他乱严重影响患者的生活质量.
- 行为疗法和药物治疗是常见的治疗方法,但直接比较是有限的.
研究的目的:
- 直接比较行为治疗 (暴露和响应预防;ERP) 与药物治疗 (瑞斯比) 的疗效,在患有图雷特障碍或滴答障碍的患者中.
- 评估对的严重程度,生活质量和治疗副作用的影响.
主要方法:
- 这是一项随机对照试验,涉及30名参与者,他们被分配给ERP (12次每周一次) 或RISPERIDONE (灵活剂量).
- 结果指标包括的严重程度 (耶鲁全球严重程度表),生活质量和副作用.
- 贝叶斯因子 (BF) 用于统计分析,BF>1表明支持假设.
主要成果:
- 在治疗结束 (BF 5.35) 和9个月的随访 (BF 4.59) 时,ERP和RISPERIDONE都有效地降低了的严重程度.
- 在3个月的随访期 (BF 3.92) 中,ERP表现出与RISPERIDONE相比的优势,并在3个月 (BF 3.70) 和9个月 (BF 3.08) 中显著改善了生活质量.
- 在RISPERIDONE组中观察到更高的断学率,主要是由于治疗早期的副作用.
结论:
- 行为治疗 (ERP) 和药物治疗 (risperidone) 是适合治疗滴答障碍的可行治疗选择.
- 由于持续减少的严重性,改善生活质量和更好的副作用概况,ERP可能会被优先考虑.
- 进一步的研究可以探索长期结果和个性化治疗策略.
相关概念视频
01:12Relative Risk
104
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
104
01:24Rational Emotive Behavior Therapy
39
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
39
01:12Hazard Ratio
72
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
72